Zebrafish model enables functional classification of COL3A1 variants of uncertain significance
A preprint from Cold Spring Harbor Laboratory describes a zebrafish system that uses functional surrogacy to model vascular Ehlers-Danlos syndrome and reclassify COL3A1 variants where pathogenicity is unclear.
Pathogenic variants in COL3A1, the gene encoding type III procollagen, cause vascular Ehlers-Danlos syndrome (vEDS), a rare connective tissue disorder characterised by arterial fragility and a markedly elevated risk of spontaneous arterial rupture or dissection. Advances in genomic sequencing have increased the number of COL3A1 variants identified in clinical settings, many of which are classified as variants of uncertain significance (VUS) — a category that creates substantial diagnostic and management difficulties for patients and their clinical teams.
A preprint posted to bioRxiv (Cold Spring Harbor Laboratory) describes a zebrafish-based functional assay designed to address this gap. Because zebrafish lack a direct COL3A1 orthologue, the authors employed a functional surrogacy strategy, introducing human COL3A1 constructs into the fish to reconstitute a tractable disease model. The system was then used to assess the functional impact of a series of COL3A1 variants, with results supporting reclassification of several VUS as either likely pathogenic or likely benign.
The work is relevant to ongoing international efforts to generate functional evidence for variant interpretation under frameworks such as those published by the American College of Medical Genetics and the ClinGen Variant Curation Expert Panels. As a preprint, the findings have not yet undergone peer review, and the assay's performance characteristics will require independent validation before any adoption into variant classification workflows.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Vascular Ehlers-Danlos syndrome (vEDS) is a rare inherited condition caused by changes — called variants — in a gene called COL3A1. This gene provides instructions for making a protein that strengthens blood vessel walls. Some people are found to carry a change in COL3A1, but scientists cannot yet say with certainty whether that change is harmful or harmless. These are called variants of uncertain significance, or VUS.
Researchers have described a new laboratory method using zebrafish to test whether specific COL3A1 variants are likely to be harmful or not. The fish were used because they are a well-established model for studying human genetic conditions. Early results suggest the approach could help reclassify some VUS, which may eventually help doctors and genetic counsellors give more precise information to families.
This research is at an early stage — it has been shared online as a preprint and has not yet been checked by independent scientific reviewers. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-07-08Functional surrogacy enables Vascular Ehlers-Danlos Syndrome modelling in zebrafish in the absence of a COL3A1 ortholog